The use of a panel of monoclonal antibodies to enrich circulating breast cancer cells facilitates their detection
- 31 August 2005
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 98 (2), 211-216
- https://doi.org/10.1016/j.ygyno.2005.04.042
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Relevance of disseminated tumour cells in blood and bone marrow of patients with solid epithelial tumours in perspectiveEuropean Journal of Surgical Oncology, 2003
- High‐resolution genomic profiling of occult micrometastatic tumor cellsGenes, Chromosomes and Cancer, 2002
- Peripheral Blood c-erbB-2 Expression by Reverse Transcriptase—Polymerase Chain Reaction in Breast Cancer Patients Receiving ChemotherapyClinical Breast Cancer, 2002
- Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patientsBritish Journal of Cancer, 2000
- Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumoursEuropean Journal Of Cancer, 2000
- Response of Circulating Tumor Cells to Systemic Therapy in Patients With Metastatic Breast Cancer: Comparison of Quantitative Polymerase Chain Reaction and Immunocytochemical TechniquesJournal of Clinical Oncology, 2000
- Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separationInternational Journal of Cancer, 1998
- Stability of HER-2/neu Expression Over Time and at Multiple Metastatic SitesJNCI Journal of the National Cancer Institute, 1993
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Selective Therapy of Metastasis. I. Quantitation of Tumorigenic Circulating and Covert Cancer Cells Disseminated from Metastatic and Nonmetastatic TumorsCancer Drug Delivery, 1984